Skip to main content

We use cookies to understand how you use our site and to improve your experience.

This includes personalizing content and advertising.

By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.

You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.

In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Back to top

PetMed Express, Inc. to Report First Quarter Fiscal 2026 Financial Results on August 13, 2026

PetMed Express will announce Q1 financial results on August 13, 2026, followed by a conference call.

Quiver AI Summary

PetMed Express, Inc., operating as PetMeds and the parent company of PetCareRx, announced that it will release its financial results for the first quarter of the fiscal year ending June 30, 2026, on August 13, 2026, after market close. A conference call and webcast will be held the same day at 4:30 PM Eastern Time to discuss the results, with details for U.S. and international dial-in numbers provided. A replay of the conference call will be available after 7:30 PM on the same day until August 27, 2026. Founded in 1996, PetMeds is a well-established online pharmacy for pet healthcare, offering a variety of pet health products and medications while focusing on convenience and care for pets and their owners.

Potential Positives

  • The announcement of the financial results and the subsequent conference call demonstrates transparency and a commitment to shareholder communication.
  • PetMed Express is preparing to report its financial performance, which can indicate potential growth or profitability and generate investor interest.
  • The company is recognized as a pioneer in the pet healthcare sector, which enhances its credibility and attractiveness to both customers and investors.
  • The availability of expert pharmacists and a wide range of pet health solutions positions PetMeds favorably in a competitive market, emphasizing its dedication to pet wellness.

Potential Negatives

  • The announcement may indicate a potential delay or lack of transparency regarding the financial results for the fiscal quarter, as the reporting date comes after the fiscal period ends.
  • There is no mention of expected financial performance or guidance for the upcoming results, which could signal uncertainty in the company's financial stability.
  • The press release lacks details on any significant developments or achievements in the quarter, which may raise concerns among investors about the company's growth and overall direction.

FAQ

When will PetMed Express report its financial results for Q1 2026?

PetMed Express will report its financial results on August 13, 2026, after market close.

What time is the PetMed Express conference call?

The conference call will be held at 4:30 PM Eastern Time on August 13, 2026.

How can I access the PetMed Express earnings webcast?

You can access the webcast through the 1Q Earnings Webcast link provided by PetMed Express.

Is there a replay available for the conference call?

Yes, a replay will be available after 7:30 PM Eastern Time on August 13, 2026, until August 27, 2026.

How long has PetMed Express been in business?

PetMed Express was founded in 1996 and has been a pioneer in direct-to-consumer pet healthcare.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


EARLY ACCESS
Receive PETS Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$PETS Insider Trading Activity

PETS Insider Trades

$PETS insiders have traded $PETS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $PETS stock by insiders over the last 6 months:

  • CAPITAL HOLDINGS INC. NINA purchased 25,000 shares for an estimated $43,725

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$PETS Revenue

PETS Quarterly Revenue

$PETS had revenues of $42.8M in Q4 2026. This is a decrease of -15.65% from the same period in the prior year.

You can track PETS financials on Quiver Quantitative's PETS stock page.

You can access data on PETS stock through the Quiver Quantitative API.

$PETS Hedge Fund Activity

We have seen 12 institutional investors add shares of $PETS stock to their portfolio, and 25 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Full Release

DELRAY BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the first quarter fiscal year ended June 30, 2026, on Thursday, August 13, 2026 after market close. The Company will host a conference call and webcast to review these results at 4:30pm Eastern Time on the same day.

Date: Thursday, August 13, 2026
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: 1Q Earnings Webcast

A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through August 27, 2026.

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13761872

About PetMed Express, Inc.

Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PetMeds family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com .

Investor Contact:
ICR, LLC
Reed Anderson
(646) 277-1260
investor@petmeds.com


Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

PetMed Express, Inc. (PETS)

Due to inactivity, you will be
signed out in approximately: